Background {#Sec1}
==========

Hypertension is the major contributor to the global burden of disease and to global mortality \[[@CR1]\]. It is defined as persistently elevated arterial blood pressure (BP), systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg \[[@CR2], [@CR3]\]. These numbers apply to all adults older than 18 years and indicate the level of BP at which the institution of therapy reduces hypertension related morbidity and mortality \[[@CR3]\], although for patients aged 60 years or older a SBP up to 150 mmHg and a DBP of less than 90 mmHg is now regarded as acceptable \[[@CR4]\]. The global prevalence of raised BP in adults aged 18 years and over was around 22% in 2014 \[[@CR5]\] and the proportion is estimated to rise to over 29% by 2025 \[[@CR6]\]. The prevalence of hypertension was highest in Africa, at 30% for all adults combined in 2014 \[[@CR7]\]. Hypertension has shown a rapid increase in prevalence affecting significant numbers of individuals in Sub- Saharan Africa \[[@CR8]\]. The prevalence in Sub- Saharan Africa is in the range of 25.4%- 41.1% in men and 27.2%- 38.7% in women \[[@CR9]\]. The reported prevalence of hypertension in different regions of Ethiopia varied widely \[[@CR10], [@CR11]\]. The prevalence in the country is estimated to be between 20% and 30% \[[@CR12]\]. Hypertension also clusters with other cardio-metabolic conditions, namely diabetes, dyslipidemia, insulin resistance, glucose intolerance and obesity \[[@CR10]\], which together increase cardiovascular disease risk \[[@CR10]--[@CR12]\].

There are several co-existing factors in diabetic patient which contribute for and accelerate the progression of the atherosclerotic vascular complications. Hypertension, which is the most prevalent and independent cardiovascular risk factor in the general population, is extremely common problem in diabetics \[[@CR4]\]. Diabetes approximately doubles risk of cardiovascular disease and concomitant hypertension nearly doubles that risk again. In addition to diabetes related renal dysfunction, hyperinsulinemia, extracellular fluid volume expansion, and increased arterial stiffness have been proposed as contributing factors for the development of hypertension in diabetics \[[@CR3]\]. Based on the evidence provided by clinical trials, current guidelines recommend that patients who have been diagnosed with cardiovascular disease and its equivalents should reduce their blood pressure to \<140/90 mmHg (so does in the case diabetics) \[[@CR7]\]. Further, it is recommended that low density lipoprotein cholesterol (LDL-C) levels should be reduced to \<100 mg/dL (2.5 mmol/L). Unfortunately, these therapeutic goals are not always attained \[[@CR4], [@CR7]\].

Drug treatments and life style interventions can be used for the management of hypertension \[[@CR2]\]. Several lifestyle interventions have been shown to reduce BP. Apart from contributing to the treatment of hypertension; these strategies are beneficial in managing most of the other cardiovascular disease (CVD) risk factors \[[@CR3]\]. Lifestyle modifications should be encouraged for all patients, regardless of stage of hypertension and includes smoking cessation, weight management, and reduction of dietary sodium intake, physical activity and moderation of alcohol consumption \[[@CR13]\]. In general, lifestyle changes should be regarded as a complement to drug therapy rather than an alternative \[[@CR7]\]. Drug treatment of hypertension depends on the degree of BP elevation and presence of compelling indications \[[@CR2]\]. Most patients with stage 1 hypertension should be initially treated with a first-line antihypertensive drug, or a combination of two agents. Combination drug therapy is recommended for patients with stage 2 hypertension using preferably two first-line antihypertensive drugs \[[@CR4]\]. According to the eighth report of the Joint National Committee (JNC 8); in the general non-black population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic, calcium channel blockers (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs); whereas in the general black population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic or CCB. For patients with chronic kidney disease (CKD), initial (or add-on) antihypertensive treatment should include an ACEI or ARB to improve kidney outcomes \[[@CR4]\]. All the first line drugs classes have comparable outcome benefits \[[@CR14]\].

The success of blood pressure management in hypertensive individuals is determined by the integrated use of optimal dose and regimen of anti-hypertensive medications together with an intervention targeted on life style modification. These have to be guided by the knowledge of the specific characteristics of patients group. Since the success of treating hypertension has been limited, and despite well-established approaches to diagnosis and treatment, in many communities fewer than half of all hypertensive patients have adequately controlled BP. This result will be expected to be lower among diabetic co-morbid patients. To date there is no single study done in Ethiopia to assess blood pressure control among hypertensive diabetics. Thus, this study is designed to highlight the status of uncontrolled hypertension in patients with type 2 diabetes and determine the associated factors, which may affect the blood pressure management and find the bottle neck and pave the way for interventions.

Methods {#Sec2}
=======

Study design and setting {#Sec3}
------------------------

A hospital based cross-sectional study design was conducted in March, 2017 at ambulatory clinic of Jimma University Medical Center (JUMC) among diabetes co-morbid hypertensive patients who fulfill the inclusion criteria. JUMC is the only teaching and referral hospital in the southwestern part of Ethiopia with bed capacity of 600. Geographically, it is located in Jimma town 352 km Southwest of Addis Ababa, the capital. It provides services for approximately 9000 inpatient and 80,000 outpatient clients per year with a catchment population of about 15 million people. All ambulatory hypertensive diabetic patients aged 18 years and older who were on antihypertensive treatment for at least 6 months before the study period and were on follow-up were included in the study.

Sample size and sampling procedure {#Sec4}
----------------------------------

The sample size was determined by using the single population proportion formula, assuming a 95% confidence interval (CI), a prevalence of 50% for blood pressure control, a 5% margin of error, and a 10% non-response rate. The final sample size was 131 diabetic hypertensive patients. Random sampling technique was used to select 131 study participants after obtaining patient list from Chronic Illness Clinic Registration Book, which had lists of 557 hypertensive patients, of which 173 were with diabetes comorbidity.

Data collection, procedure and quality control {#Sec5}
----------------------------------------------

A structured data collection questionnaire was developed by researchers from relevant literatures. Patient chart review and self-report was used to determine the various variables. Two trained data collectors interviewed the study participants and review patient charts and medical records for the respective information after all data collection tools are pre-tested. Before entry to SPSS for analysis, data was cleared, categorized, compiled and coded and also checked for completeness, accuracy. Any erroneous, ambiguous and incomplete data was excluded.

Data processing and analysis {#Sec6}
----------------------------

Data was entered into computer using EpiData version 3.1 and exported to the Statistical package for Social Science (SPSS) version 22.0 for analysis. Differences between mean values was evaluated using Student's t test while proportions was compared using the Pearson's Chi-square test. Multivariable logistic regression analyses were used to assess the crude and adjusted effect of seemingly significant predictors of the target outcome.

Categorical and continuous data was expressed as percentages and mean ± standard deviation respectively. Descriptive statistics was applied for the analysis of patient characteristics, including means, standard deviations (SD), medians, and percentiles and categorical variables was analyzed by using the chi-square test. A *p*-value of \<0.05 was considered to be statistically significant.

Ethical consideration {#Sec7}
---------------------

Ethical clearance & approval was obtained from institution review board (IRB) of Jimma University. The data that were collected from JUMC ambulatory clinic was preceded by a formal request letter from Jimma University. Written informed consent was taken from each study participant after clear orientation of the study objective. The raw data were not made available to any one and not used as the determinant of the participant. All steps in data collection and compilation were conducted and supervised by the researchers. Strict confidentiality was assured through anonymous recording and coding of questionnaires and placed in safe place. The patient got full right not to participate and as well as leave the study at any time during the study time.

Operational definitions {#Sec8}
-----------------------

■ Co-morbidity: Diseases or disorders that exist together with an index disease or co-occurrence of two or more diseases or disorders in an individual.■ Controlled BP: BP \< 140/90 mmHg in hypertensive diabetic patients of all ages \[[@CR4]\].■ Uncontrolled BP: BP ≥ 140/90 mmHg in hypertensive diabetic patients of all ages \[[@CR4]\].■ Adherent: a patient with a MMMAS score of ≥6 \[[@CR15]\] .■ Non adherent: a patient with a MMMAS scores of \<6 \[[@CR15]\].■ Physically active: an individual who perform physical exercise for at least 30 min per day for at least 5 day per week.■ Physically inactive: an individual who perform physical exercise for less than 30 min per day for less than 5 day per week \[[@CR16]\].■ Controlled blood sugar: Fasting blood sugar less than 130 mg/dL \[[@CR17]\].■ Uncontrolled blood sugar: Fasting blood sugar less than 130 mg/dL \[[@CR17]\].

Results {#Sec9}
=======

Socio-demographic and behavioral characteristics {#Sec10}
------------------------------------------------

Overall, 131 participants were included in this study. Majority of study participants were males 67 (51.14%). The mean weight of the respondents was 67.9 ± 13.01. The mean age of the respondents was 50.69 ± 13.71 and majority of them 67 (51.14%) were age of ≥50 years, 109 (83.20%) were married. Among the participants, 21(16.03%) were current smokers and 23 participants reported their current use of alcohol and 35 (26.72%) had no formal education and 44 (33.60%) were unemployed. About three forth of the study participants were found to be adherent to their medication according to a self-reported measure of adherence using the eight item MMMAS (Table [1](#Tab1){ref-type="table"}).Table 1Baseline socio-demographic characteristics of study participants at JUMC, 2017VariablesFrequencyPercentageAge(years)18--351813.7436--504635.12≥ 506751.14Weight (kg)(Mean± SD)67.9 ± 13.01GenderMale6751.14Female6448.86Marital StatusSingle118.40Married10983.20Divorced43.05Widowed75.35Educational statusNo formal education3526.72Primary school3325.19Secondary school2720.61College and above3627.48Monthly Income (ETB)No regular income4131.30\<10002116.031000--20001914.502000--30001813.74≥ 30003224.43ResidenceRural4030.53Urban9169.47Job/occupationGov't employee3022.90Non-Gov't employee1914.50Self employed3829.00Unemployed4433.60Living statusLiving with immediate family11386.25Living with Extended family107.63Living alone53.82Other\*32.30Smoker2116.03Alcoholic2317.56Chat chewer3627.48Adherence levelAdherent9774.05Non-adherent3425.95\*Living in prison

Clinical characteristics of participants {#Sec11}
----------------------------------------

The clinical characteristics of patients showed that 23 (17.56%) of participants had a family history of hypertension and 18 (13.74%) had family history of diabetes. About 46.56% and 48.10% of patients were living with hypertension and diabetes for more than five \[[@CR5]\] years, respectively. More than half the patients had a monthly follow up at JUMC ambulatory clinic. From 43 (32.82%) patients with co-morbid conditions, 21 (16.03%) had eye problem. The mean duration of time since the diagnosis of hypertension was 7.44 ± 5.11 with a range of 0.7--22 year. With regard to physical exercise; 56 (42.74%) of participants reported to perform physical exercise from whom 35(62.50%) were physically active. Among the study participants, 117 (89.31%) reduce salt in their food (Table [2](#Tab2){ref-type="table"}).Table 2Baseline clinical characteristics of study participants at JUMC, 2017VariablesFrequencyPercentageFamily history of hypertensionYes2317.56No10882.44Family history of DiabetesYes1813.74No11386.26Time since hypertension diagnosis(years)≤ 12519.082--54534.35≥ 56146.56Time since diabetes diagnosis(years)≤ 12116.032--54735.87≥ 56348.10Frequency of followup(refill)Monthly7154.20Every two months4131.30Every three months1914.50Do physical activitiesYes5642.74No7557.26Physical activeYes3562.50No2137.50Reduce salt intakeYes11789.31No1410.69Blood glucoseControlled8665.65Uncontrolled4534.35ComorbidityHeart failure53.82HIV/AIDS21.53CKD53.82Asthma32.30Retinopathy2116.03Other^a^75.34^a^Epilepsy, peripheral neuropathy

Antihypertensive and hypoglycemic medications {#Sec12}
---------------------------------------------

The overall utilization of antihypertensive drugs showed that, majority of patients were on dual antihypertensive (67.94%**).** About one thirds of the patients were on combination of enalapril and amlodipine followed by hydrochlorothiazide and enalapril (17.55%) combinations. About 8.40% of patients were taking triple antihypertensive medications. About two thirds of the patients were taking insulin (Table [3](#Tab3){ref-type="table"}).Table 3Antihypertensive & hypoglycemic Agents among study participants at JUMC, 2017MedicationsFrequencyPercentage1. Antihypertensive agentsMonotherapy3123.66 Enalapril1410.68 Amlodipine96.87 Nifedipine43.05 Hydrochlorothiazide32.29 Atenolol10.76Dual therapy8967.94 Hydrochlorothiazide + Enalapril2317.55 Hydrochlorothiazide + Atenolol75.34 Enalapril + Amlodipine4332.82 Atenolol + Amlodipine21.53 Enalapril + Atenolol129.16 Losartan +Amlodipine21.53Triple Therapy118.40 Hydrochlorothiazide + Enalapril + Amlodipine53.82 Furosemide + Enalapril +Amlodipine21.53 Metoprolol + Enalapril + Furosemide43.052. Antidiabetic agents Insulin5945.04 Oral hypoglycemic4534.35 Insulin + Oral hypoglycemic2720.61

Blood pressure control among hypertensive diabetics {#Sec13}
---------------------------------------------------

The mean SBP was 149.79 ± 16.32, while the mean DBP was 89.7 ± 9.34. More than one fourth of study participants had a controlled SBP; while about 27.48% had a controlled DBP. The overall control of BP was achieved in about 57 (43.51%) of the study participants (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Blood pressure control among study participants at JUMC, 2017

Determinants of uncontrolled blood pressure in diabetic patients {#Sec14}
----------------------------------------------------------------

The association of independent variables with the dependent variable was investigated using both univariate and multivariate logistic regression techniques. In univariate logistic regression analysis; age, gender, marital status, education level, alcohol intake, smoking, duration with hypertension (HTN), frequency of follow up, blood sugar(glycemic control), comorbidities and medication adherence showed association with BP control and hence, were used in multivariate analysis. The result of the multivariate analysis showed age to be significantly associated with uncontrolled BP in that patients aged ≥50 years were two times (AOR = 2.06; 95% CI: 2.65--7.79; *P* = 0.002) more likely to have uncontrolled BP than those \<50 years. Patients with tertiary level education were 74% (AOR = 0.26; 95% CI: 0.13--0.54; *P* = 0.03) less likely to have uncontrolled BP than those with no formal education. Gender was also found to have association with uncontrolled BP, in that female patients have 1.42 times more likely (AOR = 1.42; 95% CI: 1.19--2.14; *P* = 0.042). Duration of hypertension since diagnosis was also associated with uncontrolled BP, in that patients with a diagnosis longer than 5 years were almost three times (AOR = 2.88; 95% CI: 1.27--8.31; *P* = 0.02) more likely to have uncontrolled BP than those with a diagnosis of \<5 years. Patients with a monthly BP measurement were 35% less likely to have uncontrolled BP than those with every three months BP measurement (AOR 0.65; 95% CI: 0. 63--0.98; *P* = 0.04) and non-adherent patients were two times more likely to have uncontrolled BP than adherents (AOR 2.05; 95% CI: 2.61--9.33; *P* = 0.01). Patients with uncontrolled blood sugar (poor glycemic control) were almost two times (AOR = 1. 65; 95% CI: 2.14--3.32; P = 0.04) more likely to have uncontrolled BP than with controlled blood sugar (Table [4](#Tab4){ref-type="table"}).Table 4Determinants of uncontrolled blood pressure among study participants at JUMC, 2017VariableBlood PressureCOR (95 %CI)AOR (95 %CI)ControlledUncontrolledAge category\<50 years20441.001.00≥ 50 years37302.55 (1.72, 4.75)\*2.06 (2.65, 7.79)\*GenderMale33341.001.00Female24401. 63 (0. 98, 2. 90)\*1.42 (1.19, 2.14)\*Marital statusMarried45641.001.00Single742.721 (10.59, 13.36)3.42 (11.22, 14.12)Divorced220.55 (0.14, 5.53)0.49 (0.54, 1. 59)Widowed341.46 (0.22, 0.78)\*1.76 (0.46, 1.27)Education levelNo formal education7281.001.00Primary12212.22 (1.80, 2.84)0. 18 (0. 15, 1. 13)Secondary15121. 15 (0. 98, 2. 35)0. 07 (0.37, 1. 53)Tertiary and above23130. 27 (0. 34, 1. 12)\*0. 62 (0. 31, 0. 45)\*ResidenceRural18221.001.00Urban39520. 28 (1. 34, 11. 75)2.11 (2.47, 9.16)Monthly income (ETB)No regular income15262.17 (4.42, 6.15)1.23 (0.23, 4.74)\<10006151.06 (1.24, 3.1 5)1.09 (2.12, 6.11)1000--20009100.69 (1.79, 3.35)0.453 (0.32, 7.42)2000--30007110.66 (0. 64, 5. 59)0.23 (2.32, 9.47)≥ 300020121.001.00OccupationGov't employee2191.001.00Non-Gov't employee1360. 28 (0. 34, 1. 75)1. 10 (0. 74, 2. 61)Self employed9290.67 (0.27, 1.66)0.68 (0.25, 1.87)Unemployed14301.06 (0.60, 1.85)1.05 (0.57, 1.94)SmokingNo52581.001.00Yes5161.31 (0.75, 2.28)\*1.14 (0.62, 2.10)Alcohol intakeNo53551.001.00Yes4191.66 (0.46, 5.95)\*1.23 (0.32, 4.74)Chat chewerNo42531.001.00Yes15211.05 (0.67, 1.66)1.12 (0.68, 1.84)AdherenceAdherent49481.001.00Non-adherent8262. 37 (2.71, 8. 65)\*2.05 (2.61, 9.33)\*Frequency of follow upMonthly40310. 35 (0. 53, 0. 97)\*0. 65 (0. 63, 0. 98)\*Every 2 months10311.31 (0.75, 2.28)1. 4 2 (2. 26, 3.01)Every 3 months7121.001.00Duration with Hypertension≤ 1 year13121.001.002--5 years20250. 69 (1. 36, 11.44)1.11 (2.62, 6.63)≥ 5 years24371. 75 (1. 59, 5. 85)\*2.88 (1.27, 8.31)\*Blood SugarControlled51351.001.00Uncontrolled6392.33 (2. 11, 7. 15)\*1. 65 (2. 14,3. 32)\*ComorbidityNo40481.001.00Yes17261.04 (0. 44, 3. 31)\*1.12 (1. 22, 4. 45)Anti-HTN regimenMonotherapy13181.001.00Dual Therapy4049048 (0.13, 1.08)0.44 (1.10, 2.11)Triple therapy471.35 (1.79, 4.78)1.68 (1.19, 3.43)*ETB* Ethiopian Birr, *Anti-HTN* Antihypertensive\**P*-value less than 0.05

Discussion {#Sec15}
==========

Hypertension in patients with diabetes is a well-recognized cardiovascular risk factor \[[@CR18]\]. Recently the 8th Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC 8) concluded that BP measurement in diabetic patients should be 140/90 mmHg or less \[[@CR4]\]. Hypertension is twice as common in persons with diabetes as it is in others. Hypertension is known to contribute to diabetic micro-and macro-vascular complications \[[@CR19]\]. To reduce the risk, hypertension must be diagnosed accurately and promptly, and the patient must receive adequate treatment. However, new guidelines have been published to stress on the importance of aggressive blood pressure control in diabetic \[[@CR2]\]. This study attempted to evaluate the blood pressure control among diabetic patients in Jimma University medical center.

The result of the study showed that from a total of 131hypertensive diabetics only 43.51% of the patients met the currently recommended BP for diabetes of \<140/90 mmHg \[[@CR4]\]. The level of BP control found in this study is lower than studies from Chilean (59.7%) \[[@CR20]\], Greece (55.6%) \[[@CR19]\], USA (49.8%) \[[@CR21]\] and South Africa (57%) \[[@CR22]--[@CR24]\]. It was also lower as compared study done by Greenberg et al. \[[@CR14]\] and Berlowitz et al. \[[@CR25]\]. But, it comparable with based studies from Adama (43.6%) \[[@CR26]\] and Nigeria (42%) \[[@CR27]\], respectively. This difference in the level of BP control might be due to a diabetes comorbidity of our study population, which may indicate the need of more effort to control BP in diabetics.

This study revealed that 33 (25.20%) and 36 (27.48%) of the study participants had a controlled SBP and DBP respectively, which is lower than a report from Saudi Arabia (40.4% and 51.6%) \[[@CR28]\] and USA (55.7% and 77.1%) \[[@CR29]\].This difference in the level of control of SBP and DBP might be due to age related increase in SBP as more than half of study participants were older than 50 years of age.

As from this report age was significantly associated with uncontrolled BP in that patients aged greater 50 years were two times more likely to have uncontrolled BP than those younger than 50 years (AOR = 2.06, 95% CI: 2.65, 7.79, *P* = 0.002). It is similar to study done by in USA \[[@CR29]\] and Kenya \[[@CR30]\]. As well similar to report from Brazil \[[@CR31]\], this study showed older age as contributing factor for uncontrolled BP. In fact, an interaction between biological and behavioral factors could be used to explain our results. Regarding biological factors, a possible explanation would be the natural processes related to ageing, such as autonomous imbalance and vessels stiffening. In relation to behavioral factors, previous studies showed that older people have decreased physical activity practice \[[@CR32]\].

Educational status was also found to be associated with BP control in which patients with tertiary education were 38% (AOR = 0.26, 95% CI: 0.13, 0.54, *P* = 0.03) less likely to have uncontrolled BP when compared to those with no formal education. This result is consistent with a result obtained from Chilean HC study which showed low education level to have a negative association with BP control \[[@CR20]\]. This may be is a result of increased awareness regarding the treatment of hypertension, adherence to life style modifications to decrease BP or adherence to antihypertensive drug treatment. The result of the study showed evidence of association of frequent BP measurement with good odds of BP control in which patients with a monthly BP measurement were 35% less likely to have uncontrolled BP than those with a monthly BP measurement (AOR 0.65, 95% CI: 0. 63, 0. 98, *P* = 0.04)). This may be is a result of a health seeking behavior, frequent adjustment in life style related factors and a tendency to adhere to antihypertensive medication among those who frequently measure their BP.

Adherence to therapies is a primary determinant of treatment success. Poor adherence attenuates optimum clinical benefits and therefore reduces the overall effectiveness of treatment outcome this study showed that non adherent patients were two times more likely to have uncontrolled BP than adherents (AOR 2.05, 95% CI: 2.61, 9.33, *P* = 0.01). This result is consistent with the result obtained from studies from South Africa \[[@CR24]\], Zimbabwe \[[@CR33]\], USA \[[@CR34]\] and Nigeria \[[@CR35]\].

In light of this result, patients should be counseled and encouraged to adhere to antihypertensive medications, as adherence to antihypertensive medications is a key to achieving an optimal BP, specially, in patient needing intensive BP control, such as comorbid diabetics. Those patients with positive behavioral measures (i.e. smoking, alcohol intake and chat chewing) had higher odds of uncontrolled BP, which is consistent with study done in Saudi Arabia (8.3%) \[[@CR28]\], Oman (8%) \[[@CR36]\] and Zimbabwe (16.1%) \[[@CR33]\]. This could be secondary to the oxidative stress they impose on the cell as well as their effect on adherence \[[@CR37]\]. Thus, cessation of cigarette smoking and decreasing/stopping alcohol intake is recommended to achieve an optimal BP among patients with hypertension, specifically comorbid with diabetes. Because, this populations have additional cardiovascular risk equivalent.

This study also reveals that, not only comorbidity with diabetes, but also poor glycemic control is an independent predictor for uncontrolled BP. Patients with poor glycemic control had almost two times (AOR = 1. 65, 95% CI: 2. 14, 3. 32, *P* = 0.04) more likely to develop uncontrolled BP. This study is consistent with study done in Brazil \[[@CR31]\], by Greenberg et al. \[[@CR14]\], Berlowitz et al. \[[@CR25]\], Adler et al. \[[@CR38]\] and Jansson et al. \[[@CR17]\]. This could be explained by the pathophysiologic process related specifically to the presence of diabetes may involve excess circulating insulin. Excess circulating insulin, arising from insulin resistance in diabetes, may increase blood pressure by stimulating the sympathetic nervous system, acting as a growth factor, and/or increasing sodium reabsorption in the kidneys \[[@CR39]\]. Simply, the release of insulin following a meal stimulates vasodilation (the widening of blood vessels) in skeletal muscle while also activating the sympathetic nervous causing vasoconstriction \[[@CR40]\].

Conclusions {#Sec16}
===========

Blood pressure control to target goal was suboptimal and achieved only in almost two fifth of pharmacologically treated hypertensive diabetic patients attending ambulatory clinic of Jimma University Medical Center. Diabetic patients who were older, female, live long duration with hypertension were more likely to have uncontrolled BP. These patients can be clearly identified and therefore preventive measures should concentrate on this group of patients. Older age, female gender, duration of hypertension, non-adherence and uncontrolled blood sugar are independent predictors for uncontrolled blood pressure among hypertensive diabetic patients. Monthly follow up and higher education are protective for blood pressure control.
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